BPH
Benign proliferation of inner transitional zone of prostate gland
Increasing tissue bulk = narrowing urethral lumen
Inc prostatic smooth muscle tone (Alpha adrenergic)
Leads to Bladder obstruction
% 50-60 with BPH
% 70-80 with BPH
40%
80%
Pathophys of BPH
Age related androgen mediated epithelial and stromal hyperplaesia
BPH symptoms:
Frequency, urgency, nocturia
Hesitancy, incomplete empty, Poor flow, Post-void dribbling
BPH Ix triad
1) PSA - inc in Ca or Prostatitis
2) DRE
3) TRUSS ± biopsy
other: USS KUB (rule out hydronephrosis, urolithiasis, mass)
DDx BPH
Over active bladder
Prostatitis
Prostate Ca
UTI
Tx BPH
mild:
mod/sev
- Drug therapy + behaviour management
Abnormal:
- Surgical referral
Alph blocker:
Tamsulosin, Doxazosin
Smooth muscle relaxation in prostate and bladder neck:
SE: postural hypotension, dry mouth
5-alpha reductase inhibitors
Finasteride
Reduced conversion of testosterone to dihydrotestosterone
Complications of BPH and Tx complications
Progression of symptoms. Urinary retention (2.5% in 5 years)
Sexual dysfunction (due to alpha/5-alpha reductase inhib or surgery
TURP syndrome
What is TURP syndrome
Absorption of irrigation fluids by prostate = fluid overload, hyponatraemia (dilution), hypothermia, hypertension (reflex bradycardia)
(Rare but life threatening)
Acute urinary retention
BPH, Prostate Ca
Prolapse (cystocele, rectocele, enterocoele) , pelvic mass (fibroids, ovarian cysts, malig)
Calculi, bladder Ca, faecal impaction
Prostatitis, vulvovaginitis, cystitis
Anticholinergic (antipsych, antidepress), Alcohol, opioids
DM (ANS neuropathy), Spinal (cauda equina, cord compression, MS)
Acute urinary retention Pres
Uncomfortable
Unable to pass urine
Tender + distended bladder
Urinary retention Ix
USS bladder
Urinalysis: infection,
U&E, Cr, GFR
Looking for cause:
Acute urinary retention Tx and complications
Immediate catheter decompression
Tx according to cause
Complications: AKI, UTI
Prostate Ca:
Adenocarcinoma from peripheral prostate
Local: capsule to seminal vesicles, bladder, rectum
Pelvic LNs
Haematogenous: 90% of mets sclerotic bone lesion, lung and liver
Most common male cancer (80% incidence over 80)
+ve FH, inc testosterone
BRCA and HPC-1
(hereditary Prostate Ca gene)
Prostate Ca grading score
Gleason - Each biopsy is Graded 1-5 - Two strongest scored biopsies added together Low = 0-6 High = 8-10
Pros and Cons for Prostate Ca screening
Pro: commonest male Ca, 3% of all men die of Prostate Ca
Con: uncertain natural history (some low and some high aggressive), PSA non-specific
Prostate Ca Pres
Male over 50 LUTS: Storage and voiding symptoms Haematuria Weight loss Lethargy Bone pain (mets) LN palpable (mets)
Prostate Ca Investigations
PSA: prostate but not Ca specific (normal 0-4ng/ml)
DRE - hard irregular prostate
TRUSS + Biopsy
MRI/CT for staging
Isotope bone scan for mets (esp if PSA over 20)
Prostate Ca Severity
Low risk (PSA under 10, Gleason under 6)
Intermediate risk (Gleason 6-8)
High risk (Gleason 8-10, PSA over 20)
Prostat Ca Treatment
Low risk/intermediate
High risk
Tx of mets in Prostate Ca
Castration (usually chemical) through androgen deprivation therapy
- Goserelin: GnRH so first stimulates and then acts as negative feedback to inhibit release of androgen
80% mets androgen sensitive so Tx = remission
Bisphosphonates/radiotherapy to reduce hypercalcaemia in resistent
What type of epithelium in Bladder.
What type of cells at surface
Transitional epithelium
Umbrella cells